Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti-Cancer Agents

Volume 6

eBook: US $79 Special Offer (PDF + Printed Copy): US $145
Printed Copy: US $105
Library License: US $316
ISSN: 2451-8905 (Print)
ISSN: 2215-0803 (Online)
ISBN: 978-981-14-7841-3 (Print)
ISBN: 978-981-14-7843-7 (Online)
Year of Publication: 2021
DOI: 10.2174/97898114784371200601

Introduction

Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers.

The sixth volume of the book features reviews on these topics:

- Immunomodulating Agents in The Treatment of Acute Myeloid Leukemia

- Potential Natural Products for Prostate Cancer Management

- Inhibition of Key Protein-Protein Interactions by Small Molecules for Cancer Drug Design

- Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) For Advanced Hepatocellular Carcinoma

- Targeting Cancer Stem Cells: Implications in Health and Disease

Contributors

Editor(s):
Atta-ur-Rahman
Honorary Life Fellow
University of Cambridge
Cambridge
UK




Contributor(s):
Ademar A. da Silva Filho
Faculty of Pharmacy
Department of Pharmaceutical Sciences, Federal University of Juiz de Fora
Juiz de Fora
Brazil


Aykut Özgür
Tokat Gaziosmanpaşa University
Artova Vocational School, Department of Veterinary Medicine, Laboratory and Veterinary Health Program
Tokat
Turkey


Bilal Rah
Immunology and Molecular Medicine
Sher-i-Kashmir Institute of Medical Sciences
Jammu and Kashmir
India


Danilo S. Costa
Faculty of Pharmacy
Department of Pharmaceutical Sciences, Federal University of Juiz de Fora
Juiz de Fora
Brazil


Dil Afroze
Adavnced Centre for Human Genetics
Sheri-Kashmir Institute of Medical Sciences
Jammu and Kashmir
India


Douglas C. Brandão
Institute of Biotechnology
Federal University of Uberlandia
Uberlandia
Brazil


Ezgi Nurdan Yenilmez Tunoğlu
Istanbul University
Aziz Sancar Institutes of Health, Division of Molecular Medicine
Istanbul
Turkey


Firdous A. Khanday
Department of Biotechnology
University of Kashmir, Srinagar,
Jammu and Kashmir-190006
India


Gabriela S. Guimarães
Institute of Biotechnology
Federal University of Uberlandia
Uberlandia
Brazil


Hilal Ahmad Mir
Department of Biotechnology
University of Kashmir, Srinagar,
Jammu and Kashmir-190006
India


Hitoshi Yoshiji
Department of Gastroenterology and Hepatology
Nara Medical University, Address: 840 Shijo-cho
Kashihara, Nara 634-8522
Japan


Igor M. Campos
Faculty of Pharmacy
Department of Pharmaceutical Sciences, Federal University of Juiz de Fora
Juiz de Fora
Brazil


İrfan Koca
Yozgat Bozok University
Faculty of Arts and Sciences, Department of Chemistry
Yozgat
Turkey


Javid Rasool
Department of Haematology
Sher-i-Kashmir Institute of Medical Sciences [SKIMS]
Jammu and Kashmir
India


Kei Moriya
Department of Gastroenterology and Hepatology
Nara Medical University, Address: 840 Shijo-cho
Kashihara, Nara 634-8522
Japan


Khurshid I. Andrabi
Department of Biotechnology
University of Kashmir
Jammu and Kashmir
India


Lara Vecchi
Institute of Biotechnology
Federal University of Uberlandia
Uberlandia
Brazil


Lütfi Tutar
Ahi Evran University
Faculty of Science, Department of Molecular Biology and Genetics
Kırşehir
Turkey


Mariana A.P. Zóia
Institute of Biotechnology
Federal University of Uberlandia
Uberlandia
Brazil


Matheus A. Ribeiro
Institute of Biotechnology
Federal University of Uberlandia
Uberlandia
Brazil


Mehmet Gümüş
Yozgat Bozok University
Akdağmadeni Health College
Yozgat
Turkey


Paula M.A.P. Lima
Institute of Biotechnology
Federal University of Uberlandia
Uberlandia
Brazil


Rabia Hamid
Department of Nanotechnology
University of Kashmir, Srinagar
Jammu and Kashmir-190006
India


Roshia Ali
Department of Biochemistry
University of Kashmir, Srinagar,
Jammu and Kashmir-190006
India
/
Department of Biotechnology
University of Kashmir, Srinagar,
Jammu and Kashmir-190006
India


Sahar Saleem Bhat
Division of Biotechnology
SKUAST-K, FVSc& AH, Shuhama, Srinagar
Jammu and Kashmir
India


Sara T.S. Mota
Institute of Biotechnology
Federal University of Uberlandia
Uberlandia
Brazil


Servet Tunoğlu
Istanbul University
Aziz Sancar Institutes of Health, Division of Molecular Medicine
Istanbul
Turkey


Shazia Ali
Adavnced Centre for Human Genetics
Sheri-Kashmir Institute of Medical Sciences
Jammu and Kashmir
India


Tadashi Namisaki
Department of Gastroenterology and Hepatology
Nara Medical University, Address: 840 Shijo-cho
Kashihara, Nara 634-8522
Japan


Thaise G. Araújo
Institute of Biotechnology
Federal University of Uberlandia
Uberlandia
Brazil


Yusuf Tutar
University of Health Sciences
Hamidiye Institute of Health Sciences, Division of Molecular Oncology
Istanbul
Turkey
/
Hamidiye Faculty of Pharmacy
Department of Basic Pharmaceutical Sciences, Division of Biochemistry
Istanbul
Turkey




RELATED BOOKS

.Frontiers in Clinical Drug Research - Anti-Cancer Agents.
.Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach.
.The Management of Metastatic Triple-Negative Breast Cancer: An Integrated and Expeditionary Approach.
.Cancer Medicine in an Ayurvedic Perspective: A Critical Overview.